The FLEXcyte brings another dimension to iPS-derived cardiomyocyte based assays. Measuring contractility in such a direct and easy way allows us to understand the cell functionality better and will help us in both our product development and safety pharmacology research.
Nexel
- Post date August 20, 2020
News
- innoVation Series December 22 / January 23With the New Year we are focussing on the importance of human iPSC-derived cardiomyocyte beat rate […]
- Meet us at the 62nd Society of Toxicology Annual Meeting in Nashville, USAThe SOT conference will take place in March 19 – 23, 2023. Keep an eye out for more […]
- innoVation Series October / November 2022The October issue of the innoVation series is a special workshop report of the FDA (Pang et al., […]
